Oral Piwi‐Interacting RNA Delivery Mediated by Green Tea‐Derived Exosome‐Like Nanovesicles for the Treatment of Aortic Dissection
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202401466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Yan Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, No. 38 Dengzhou Road, Qingdao, 266021, P. R. China. Hauptthemen laut MEDLINE: Exosomes, RNA, Small Interfering, Aortic Dissection, Tea. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Qingdao Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Aortic dissection (AD) is a severe cardiovascular disease necessitating active therapeutic strategies for early intervention and prevention. Nucleic acid drugs, known for their potent molecule‐targeting therapeutic properties, offer potential for genetic suppression of AD. Piwi‐interacting RNAs, a class of small RNAs, hold promise for managing cardiovascular diseases. Limited research on these RNAs and AD exists. This study demonstrates that an antagomir targeting heart‐apoptosis‐associated piRNA (HAAPIR) effectively regulates vascular remodeling, mitigating AD occurrence and progression through the myocyte enhancer factor 2D (Mef2D) and matrix metallopeptidase 9 (MMP9) pathways. Green tea‐derived plant exosome‐like nanovesicles (PELNs) are used for oral administration of antagomir. The antagomir‐HAAPIR‐nanovesicle complex, after purification and optimization, exhibits a high packing rate, while the antagomir is resistant to enzyme digestion. Administered to mice, the complex targets the aortic lesion, reducing AD incidence and improving survival. Moreover, MMP9 and Mef2D expression decrease significantly, inhibiting the phenotypic conversion of human aortic smooth muscle cells. PELNs encapsulate the antagomir‐HAAPIR complex, maintaining stability, mediating transport into the bloodstream, and delivering Piwi‐interacting RNAs to AD sites. Thus, HAAPIR is a potential target for persistent clinical AD prevention and treatment, and nanovesicle‐encapsulated nucleic acids offer a promising cardiovascular disease treatment, providing insights for other therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, No. 38 Dengzhou Road, Qingdao, 266021, P. R. China.
- Department of Integrative Biotechnology, Sungkyunkwan University, 300 Chuncheon-Dong, Suwon, 16419, Republic of Korea.
- Clinical Laboratory, Central Laboratory, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao, 266000, P. R. China.
- Department of Immunology, School of Basic Medicine, Qingdao University, Qingdao, 266021, P. R. China.
- Department of Cardiac Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266000, P. R. China.
ORCID-Profile: Tao Yu
Förderung
- National Natural Science Foundation of China
- Qingdao Municipal Science and Technology Bureau
Zitieren
APA
Liu, Y., Qi, H., Zong, J., Li, M., Yang, Y., Li, X., Li, T., Cho, J. Y., & Yu, T. (2024). Oral Piwi‐Interacting RNA Delivery Mediated by Green Tea‐Derived Exosome‐Like Nanovesicles for the Treatment of Aortic Dissection. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401466
Vancouver
Liu Y, Qi H, Zong J, Li M, Yang Y, Li X, et al. Oral Piwi‐Interacting RNA Delivery Mediated by Green Tea‐Derived Exosome‐Like Nanovesicles for the Treatment of Aortic Dissection. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401466
BibTeX
@article{Liu2024,
author = {Liu, Yan and Qi, Hongzhao and Zong, Jinbao and Li, Min and Yang, Yanyan and Li, Xiaolu and Li, Tianxiang and Cho, Jae Youl and Yu, Tao},
title = {Oral Piwi‐Interacting RNA Delivery Mediated by Green Tea‐Derived Exosome‐Like Nanovesicles for the Treatment of Aortic Dissection},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202401466}
}
EUVIMED